US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 7.060
  • -0.160-2.22%
Close Dec 27 16:00 ET
  • 7.400
  • +0.340+4.82%
Post 20:01 ET
433.74MMarket Cap-3.97P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
9.22M
4.7M
1.06M
0
0
0
0
0
0
0
Operating revenue
--9.22M
--4.7M
--1.06M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.31%35.74M
0.31%37.34M
5.11%36.01M
27.52%143.31M
7.31%34.86M
30.34%36.97M
36.69%37.22M
40.97%34.26M
54.20%112.38M
38.92%32.49M
Selling and administrative expenses
-6.17%8.13M
13.96%9.28M
19.74%8.99M
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
-General and administrative expense
-6.17%8.13M
13.96%9.28M
19.74%8.99M
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
Research and development costs
-2.44%27.62M
-3.51%28.06M
1.01%27.03M
30.81%111.27M
9.12%27.14M
32.63%28.31M
38.88%29.08M
49.34%26.76M
48.83%85.06M
37.16%24.87M
Operating profit
28.24%-26.53M
12.30%-32.64M
-2.01%-34.95M
-27.52%-143.31M
-7.31%-34.86M
-30.34%-36.97M
-36.69%-37.22M
-40.97%-34.26M
-54.20%-112.38M
-38.92%-32.49M
Net non-operating interest income expense
29.86%2.89M
14.55%2.64M
0.21%2.44M
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
Non-operating interest income
29.86%2.89M
14.55%2.64M
0.21%2.44M
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
Other net income (expense)
-666.67%-153K
23.19%-53K
387.04%620K
-971.43%-1.04M
-175.27%-779K
-42.55%27K
-151.49%-69K
-197.74%-216K
110.61%119K
-328.79%-283K
Gain on sale of security
-666.67%-153K
43.01%-53K
387.04%620K
-10,710.00%-1.06M
-175.27%-779K
-57.14%27K
-169.40%-93K
-325.00%-216K
106.17%10K
-328.79%-283K
Special income (charges)
--0
--0
----
-77.98%24K
--0
--0
--24K
----
--109K
--0
-Gain on sale of property,plant,equipment
--0
--0
----
-77.98%24K
--0
--0
--24K
----
--109K
--0
Income before tax
31.47%-23.79M
14.09%-30.06M
0.48%-31.89M
-24.44%-135.01M
-8.10%-33.27M
-27.07%-34.71M
-32.18%-34.99M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Income tax
-58.24%71K
32.63%252K
83K
338K
-22K
170K
190K
0
0
0
Net income
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Net income continuous Operations
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Minority interest income
Net income attributable to the parent company
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.60%-23.86M
13.84%-30.31M
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
Basic earnings per share
58.57%-0.29
39.44%-0.43
18.46%-0.53
-14.35%-2.63
7.94%-0.58
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
Diluted earnings per share
58.57%-0.29
39.44%-0.43
18.46%-0.53
-14.35%-2.63
7.94%-0.58
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 9.22M4.7M1.06M0000000
Operating revenue --9.22M--4.7M--1.06M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.31%35.74M0.31%37.34M5.11%36.01M27.52%143.31M7.31%34.86M30.34%36.97M36.69%37.22M40.97%34.26M54.20%112.38M38.92%32.49M
Selling and administrative expenses -6.17%8.13M13.96%9.28M19.74%8.99M17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M
-General and administrative expense -6.17%8.13M13.96%9.28M19.74%8.99M17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M
Research and development costs -2.44%27.62M-3.51%28.06M1.01%27.03M30.81%111.27M9.12%27.14M32.63%28.31M38.88%29.08M49.34%26.76M48.83%85.06M37.16%24.87M
Operating profit 28.24%-26.53M12.30%-32.64M-2.01%-34.95M-27.52%-143.31M-7.31%-34.86M-30.34%-36.97M-36.69%-37.22M-40.97%-34.26M-54.20%-112.38M-38.92%-32.49M
Net non-operating interest income expense 29.86%2.89M14.55%2.64M0.21%2.44M147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M
Non-operating interest income 29.86%2.89M14.55%2.64M0.21%2.44M147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M
Other net income (expense) -666.67%-153K23.19%-53K387.04%620K-971.43%-1.04M-175.27%-779K-42.55%27K-151.49%-69K-197.74%-216K110.61%119K-328.79%-283K
Gain on sale of security -666.67%-153K43.01%-53K387.04%620K-10,710.00%-1.06M-175.27%-779K-57.14%27K-169.40%-93K-325.00%-216K106.17%10K-328.79%-283K
Special income (charges) --0--0-----77.98%24K--0--0--24K------109K--0
-Gain on sale of property,plant,equipment --0--0-----77.98%24K--0--0--24K------109K--0
Income before tax 31.47%-23.79M14.09%-30.06M0.48%-31.89M-24.44%-135.01M-8.10%-33.27M-27.07%-34.71M-32.18%-34.99M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Income tax -58.24%71K32.63%252K83K338K-22K170K190K000
Net income 31.60%-23.86M13.84%-30.31M0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Net income continuous Operations 31.60%-23.86M13.84%-30.31M0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Minority interest income
Net income attributable to the parent company 31.60%-23.86M13.84%-30.31M0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.60%-23.86M13.84%-30.31M0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M
Basic earnings per share 58.57%-0.2939.44%-0.4318.46%-0.53-14.35%-2.637.94%-0.58-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63
Diluted earnings per share 58.57%-0.2939.44%-0.4318.46%-0.53-14.35%-2.637.94%-0.58-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data